Characterization of the temporal profile of the antinociceptive effects of an intravenous bolus of ketamine using the analgesia nociception index in no-anesthetized adult patients

  • 0Servicio de Anestesiología, Clínica Central Cira García, La Habana, Cuba.

|

|

Summary

This summary is machine-generated.

This study developed a pharmacokinetic-pharmacodynamic model for ketamine

Area Of Science

  • Pharmacology
  • Anesthesiology
  • Pharmacometrics

Background

  • Precise titration of intravenous analgesics requires effect-site target-controlled infusion (TCI).
  • The analgesia nociception index (ANI) monitors the balance between analgesia and nociception during general anesthesia.
  • Understanding ketamine's antinociceptive effects is crucial for optimizing its use in anesthesia.

Purpose Of The Study

  • To derive a pharmacokinetic-pharmacodynamic (PKPD) model for ketamine's antinociceptive effect.
  • To characterize the time lag between ketamine plasma concentrations and ANI response using the Domino PK parameter set.
  • To establish parameters for potential effect-site TCI of ketamine for analgesia.

Main Methods

  • Twenty awake adult patients received a single intravenous bolus of ketamine (0.1 mg·kg⁻¹).
  • ANI values were recorded, and a PKPD model incorporating the Domino PK parameter set and an effect compartment was used.
  • Model parameters were estimated using NONMEM® 7.5, with Ke0 characterizing the effect-site time lag.

Main Results

  • Ketamine administration increased basal ANI values from 38.5 ± 4.95 to a maximum of 53.5 ± 4.95.
  • The time-to-peak effect was observed at 1.83 ± 0.74 min.
  • A Ke0 value of 0.238 min⁻¹ (95% CI 0.20-0.28) was estimated, characterizing the hysteresis between plasma concentrations and ANI response.

Conclusions

  • The developed PKPD model adequately characterized the temporal profile of ketamine's antinociceptive effect.
  • The estimated model parameters support the feasibility of effect-site TCI for ketamine analgesia.
  • This model provides a foundation for more precise ketamine administration in clinical settings.

Related Concept Videos

Parenteral Anesthetics: Overview 01:24

101

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia 01:16

365

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...

Local Anesthetics: Adverse Effects 01:12

391

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...

Local Anesthetics: Pharmacokinetics 01:13

735

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...

Opioid Analgesics: Synthetic and Semisynthetic Opioids 01:15

230

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Local Anesthetics: Clinical Application as Spinal Anesthesia 01:11

584

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...